Clinical Trials Browser

OTHER × Gefitinib × Dermatologic × Clear all

NCT00054691 2015-03-13

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Phase 2 Completed

40 enrolled 6 charts

Skin Neoplasms